Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant neoplasm (MN) is one of the most significant risk...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko
Materiálatiipa: Artihkal
Giella:Russian
Almmustuhtton: «REMEDIUM GROUP» Ltd. 2023-01-01
Ráidu:Атеротромбоз
Fáttát:
active cancer
multifocal atherosclerosis
d-dimer
gdf-15
vegf-a
prognosis determining outcomes
Liŋkkat:https://www.aterotromboz.ru/jour/article/view/287

Interneahtta

https://www.aterotromboz.ru/jour/article/view/287

Geahča maid